Greenlight Biosciences Hldgs Pbc (GRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,469 | -167,055 | -128,291 | -90,133 | -38,207 |
| Depreciation Amortization | 2,334 | 8,076 | 6,578 | 4,543 | 2,096 |
| Accounts receivable | N/A | N/A | N/A | -10,000 | -5,000 |
| Accounts payable and accrued liabilities | 233 | -6,612 | -4,002 | -2,979 | -1,952 |
| Other Working Capital | -8,146 | 8,406 | 3,529 | 10,532 | -17,903 |
| Other Operating Activity | 2,988 | 20,454 | 10,044 | 15,872 | 11,455 |
| Operating Cash Flow | $-31,060 | $-136,731 | $-112,142 | $-72,165 | $-49,511 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,608 | -26,510 | -22,907 | -12,833 | -250 |
| Investing Cash Flow | $-1,608 | $-26,510 | $-22,907 | $-12,833 | $-250 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 100,293 | 21,750 | 21,750 | 21,750 |
| Debt Repayment | -3,024 | -7,228 | -5,129 | -3,059 | -975 |
| Common Stock Issued | 35 | 107,786 | 107,981 | 1,545 | 1,231 |
| Other Financing Activity | 0 | 0 | 78,313 | 78,407 | 80,491 |
| Financing Cash Flow | $-2,989 | $200,851 | $202,915 | $98,643 | $102,497 |
| Beginning Cash Position | 69,418 | 31,808 | 31,808 | 31,808 | 31,808 |
| End Cash Position | 33,761 | 69,418 | 99,674 | 45,453 | 84,544 |
| Net Cash Flow | $-35,657 | $37,610 | $67,866 | $13,645 | $52,736 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,060 | -136,731 | -112,142 | -72,165 | -49,511 |
| Capital Expenditure | -1,608 | -26,547 | -22,944 | -12,870 | -287 |
| Free Cash Flow | -32,668 | -163,278 | -135,086 | -85,035 | -49,798 |